• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

标记的双脱水半乳糖醇在人脑胶质瘤和神经组织中的摄取。

Uptake of labeled dianhydrogalactitol into human gliomas and nervous tissue.

作者信息

Eckhardt S, Csetényi J, Horváth I P, Kerpel-Fronius S, Számel I, Institóris L, Szlovik F, Pásztor E, Afra D

出版信息

Cancer Treat Rep. 1977 Aug;61(5):841-7.

PMID:890693
Abstract

The distribution of iv administered 3H-dianhydrogalactitol (DAG) in the plasma, cerebrospinal fluid (CSF), brain, and tumor tissue was studied in 11 patients. DAG entered the CSF and was slowly eliminated, with a half-life of 20 hours. Unchanged DAG accounted for about 6%-30% of the total radioactivity in the CSF. All the tumors accumulated the drug to a higher extent than the intact white matter, except the one meningioma studied. The highest uptake was observed in the relatively benign astrocytic tumors.

摘要

对11例患者静脉注射3H-双脱水半乳糖醇(DAG)后在血浆、脑脊液(CSF)、脑和肿瘤组织中的分布进行了研究。DAG进入脑脊液并缓慢消除,半衰期为20小时。未变化的DAG约占脑脊液中总放射性的6%-30%。除所研究的1例脑膜瘤外,所有肿瘤对药物的蓄积程度均高于完整白质。在相对良性的星形细胞瘤中观察到最高摄取量。

相似文献

1
Uptake of labeled dianhydrogalactitol into human gliomas and nervous tissue.标记的双脱水半乳糖醇在人脑胶质瘤和神经组织中的摄取。
Cancer Treat Rep. 1977 Aug;61(5):841-7.
2
Studies on the distribution of dianhydrogalactitol into the central nervous system of the rat.二去水半乳糖醇在大鼠中枢神经系统中的分布研究。
Cancer Treat Rep. 1978 Mar;62(3):409-12.
3
A preliminary Pharmacokinetic study of dianhydrogalactitol (NSC-132313) disposition in the dog.二去水半乳糖醇(NSC-132313)在犬体内处置的初步药代动力学研究。
J Natl Cancer Inst. 1977 May;58(5):1311-4. doi: 10.1093/jnci/58.5.1311.
4
Phase II study of VP-16-213 versus dianhydrogalactitol in patients with metastatic malignant melanoma.VP-16-213与双去水半乳糖醇治疗转移性恶性黑色素瘤患者的II期研究。
Cancer Treat Rep. 1976 Nov;60(11):1681-2.
5
Phase I evaluation of dianhydrogalactitol (NSC-132313).双脱水半乳糖醇(NSC - 132313)的I期评估
Cancer Treat Rep. 1976 May;60(5):611-4.
6
Phase II study of dianhydrogalactitol and ICRF-159 in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy.双去水半乳糖醇与ICRF-159治疗既往接受过细胞毒性化疗的晚期乳腺癌患者的II期研究。
Cancer Treat Rep. 1977 Jan-Feb;61(1):81-2.
7
Interaction of GGCC sequences of DNA with anticancer dianhydrogalacticol, detected by inhibition of restriction enzyme BspI.
Acta Biochim Biophys Acad Sci Hung. 1984;19(3-4):177-84.
8
The distribution of lithium into cerebrospinal fluid, brain tissue and bile in man.
Int J Clin Pharmacol Biopharm. 1978 Jul;16(7):333-5.
9
Clinical and pharmacologic evaluation of split-dose intermittent therapy with dianhydrogalactitol.二去水半乳糖醇分剂量间歇疗法的临床与药理学评估
Cancer Treat Rep. 1982 Feb;66(2):283-7.
10
Dianhydrogalactitol (NSC-132313): pharmacokinetics in normal and tumor-bearing rat brain and antitumor activity against three intracerebral rodent tumors.二去水半乳糖醇(NSC-132313):在正常及荷瘤大鼠脑内的药代动力学以及对三种脑内啮齿类肿瘤的抗肿瘤活性
J Natl Cancer Inst. 1976 Mar;56(3):535-9. doi: 10.1093/jnci/56.3.535.

引用本文的文献

1
Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells.联合替莫唑胺或二脱水半乳糖醇抑制DNA修复可克服替莫唑胺耐药的胶质瘤细胞。
Cancers (Basel). 2021 May 24;13(11):2570. doi: 10.3390/cancers13112570.
2
Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology.患者来源的类器官和原发及复发性脑胶质瘤的原位异种移植为精准肿瘤学提供了相关的患者替身。
Acta Neuropathol. 2020 Dec;140(6):919-949. doi: 10.1007/s00401-020-02226-7. Epub 2020 Oct 3.
3
Dianhydrogalactitol synergizes with topoisomerase poisons to overcome DNA repair activity in tumor cells.
二聚醇与拓扑异构酶抑制剂协同作用以克服肿瘤细胞中的 DNA 修复活性。
Cell Death Dis. 2020 Jul 24;11(7):577. doi: 10.1038/s41419-020-02780-8.
4
Dianhydrogalactitol induces replication-dependent DNA damage in tumor cells preferentially resolved by homologous recombination.二羟甘露醇诱导肿瘤细胞中依赖复制的 DNA 损伤,这些损伤可被同源重组优先修复。
Cell Death Dis. 2018 Oct 3;9(10):1016. doi: 10.1038/s41419-018-1069-9.
5
1,2:5,6-dianhydrogalactitol inhibits human glioma cell growth in vivo and in vitro by arresting the cell cycle at G/M phase.1,2:5,6-二去水半乳糖醇通过将细胞周期阻滞在G/M期来抑制人胶质瘤细胞在体内和体外的生长。
Acta Pharmacol Sin. 2017 Apr;38(4):561-570. doi: 10.1038/aps.2016.154. Epub 2017 Feb 20.
6
A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors.血脑屏障在人类脑肿瘤化疗中作用的批判性分析
J Neurooncol. 1994;20(2):121-39. doi: 10.1007/BF01052723.
7
Chemotherapeutic approaches to brain tumors. Experimental observations with dianhydrogalactitol and dibromodulcitol.脑肿瘤的化疗方法。双脱水半乳糖醇和二溴卫矛醇的实验观察
Cancer Chemother Pharmacol. 1982;8(1):125-31. doi: 10.1007/BF00292883.